NZ773159A - Probiotic drops and preparation method - Google Patents
Probiotic drops and preparation methodInfo
- Publication number
- NZ773159A NZ773159A NZ773159A NZ77315921A NZ773159A NZ 773159 A NZ773159 A NZ 773159A NZ 773159 A NZ773159 A NZ 773159A NZ 77315921 A NZ77315921 A NZ 77315921A NZ 773159 A NZ773159 A NZ 773159A
- Authority
- NZ
- New Zealand
- Prior art keywords
- oil
- olive oil
- probiotics
- tea polyphenols
- medium
- Prior art date
Links
- 230000000529 probiotic Effects 0.000 title claims abstract description 57
- 239000006041 probiotic Substances 0.000 title claims abstract description 57
- 235000018291 probiotics Nutrition 0.000 title claims abstract description 57
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- 239000004006 olive oil Substances 0.000 claims abstract description 48
- 239000003921 oil Substances 0.000 claims abstract description 47
- 235000019198 oils Nutrition 0.000 claims abstract description 47
- 235000008390 olive oil Nutrition 0.000 claims abstract description 47
- 229940057917 Medium chain triglycerides Drugs 0.000 claims abstract description 45
- 230000000694 effects Effects 0.000 claims abstract description 32
- 239000000126 substance Substances 0.000 claims abstract description 11
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims abstract description 8
- 235000013824 polyphenols Nutrition 0.000 claims description 52
- 150000008442 polyphenolic compounds Chemical class 0.000 claims description 50
- 239000000203 mixture Substances 0.000 claims description 23
- 238000002156 mixing Methods 0.000 claims description 22
- 239000000047 product Substances 0.000 claims description 12
- 239000012467 final product Substances 0.000 claims description 10
- 150000002500 ions Chemical class 0.000 claims description 8
- 230000001954 sterilising Effects 0.000 claims description 8
- 238000004659 sterilization and disinfection Methods 0.000 claims description 8
- 239000000843 powder Substances 0.000 claims description 7
- 238000007792 addition Methods 0.000 claims description 6
- 239000002245 particle Substances 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 150000002085 enols Chemical class 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- 241001122767 Theaceae Species 0.000 claims 5
- 210000000350 MC(T) Anatomy 0.000 claims 3
- HVYWMOMLDIMFJA-DPAQBDIFSA-N (3β)-Cholest-5-en-3-ol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract description 20
- 210000004369 Blood Anatomy 0.000 abstract description 17
- 239000008280 blood Substances 0.000 abstract description 17
- 229940107161 Cholesterol Drugs 0.000 abstract description 10
- ONCXFUAOAOCNRC-QZOPMXJLSA-N (Z)-docos-13-enoic acid;(Z)-octadec-9-enoic acid Chemical class CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCCCCCC(O)=O ONCXFUAOAOCNRC-QZOPMXJLSA-N 0.000 abstract description 7
- 235000012000 cholesterol Nutrition 0.000 abstract description 7
- 150000002632 lipids Chemical class 0.000 abstract description 7
- 235000021281 monounsaturated fatty acids Nutrition 0.000 abstract description 7
- 229940029983 VITAMINS Drugs 0.000 abstract description 6
- 229940021016 Vitamin IV solution additives Drugs 0.000 abstract description 6
- 235000013343 vitamin Nutrition 0.000 abstract description 6
- 239000011782 vitamin Substances 0.000 abstract description 6
- 229930003231 vitamins Natural products 0.000 abstract description 6
- 238000009825 accumulation Methods 0.000 abstract description 5
- 208000008787 Cardiovascular Disease Diseases 0.000 abstract description 4
- 201000001084 cerebrovascular disease Diseases 0.000 abstract description 3
- 150000003626 triacylglycerols Chemical class 0.000 abstract description 3
- 235000013616 tea Nutrition 0.000 description 57
- 244000269722 Thea sinensis Species 0.000 description 52
- 230000036541 health Effects 0.000 description 39
- 241000894006 Bacteria Species 0.000 description 23
- 230000002708 enhancing Effects 0.000 description 17
- 210000000936 Intestines Anatomy 0.000 description 15
- 238000011156 evaluation Methods 0.000 description 14
- 239000003925 fat Substances 0.000 description 13
- 235000019197 fats Nutrition 0.000 description 13
- 230000036039 immunity Effects 0.000 description 13
- 210000002784 Stomach Anatomy 0.000 description 12
- 230000001105 regulatory Effects 0.000 description 11
- 238000005728 strengthening Methods 0.000 description 11
- 241000519995 Stachys sylvatica Species 0.000 description 9
- 230000000968 intestinal Effects 0.000 description 9
- 230000002633 protecting Effects 0.000 description 9
- 241000219430 Betula pendula Species 0.000 description 8
- 210000001035 Gastrointestinal Tract Anatomy 0.000 description 8
- 230000001953 sensory Effects 0.000 description 8
- 230000035943 smell Effects 0.000 description 8
- 230000003064 anti-oxidating Effects 0.000 description 7
- 230000003078 antioxidant Effects 0.000 description 7
- 150000001765 catechin Chemical class 0.000 description 7
- 230000002401 inhibitory effect Effects 0.000 description 7
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 7
- 239000004310 lactic acid Substances 0.000 description 7
- 235000014655 lactic acid Nutrition 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 230000001580 bacterial Effects 0.000 description 6
- 229930016253 catechin Natural products 0.000 description 6
- 235000005487 catechin Nutrition 0.000 description 6
- 239000000306 component Substances 0.000 description 6
- 244000005700 microbiome Species 0.000 description 6
- 241000894007 species Species 0.000 description 6
- 239000003963 antioxidant agent Substances 0.000 description 5
- 235000006708 antioxidants Nutrition 0.000 description 5
- 238000001816 cooling Methods 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 230000001717 pathogenic Effects 0.000 description 5
- 235000003441 saturated fatty acids Nutrition 0.000 description 5
- 150000004671 saturated fatty acids Chemical class 0.000 description 5
- 241000186012 Bifidobacterium breve Species 0.000 description 4
- 210000004204 Blood Vessels Anatomy 0.000 description 4
- 210000001072 Colon Anatomy 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 241000218588 Lactobacillus rhamnosus Species 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 230000003712 anti-aging Effects 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 201000008286 diarrhea Diseases 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 230000014860 sensory perception of taste Effects 0.000 description 4
- 235000000346 sugar Nutrition 0.000 description 4
- 235000019640 taste Nutrition 0.000 description 4
- 230000035917 taste Effects 0.000 description 4
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 4
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 4
- 206010003210 Arteriosclerosis Diseases 0.000 description 3
- 241000186000 Bifidobacterium Species 0.000 description 3
- 241000282412 Homo Species 0.000 description 3
- 240000004403 Lactobacillus casei Species 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 241000736262 Microbiota Species 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N acetic acid ethyl ester Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 230000001093 anti-cancer Effects 0.000 description 3
- 230000003471 anti-radiation Effects 0.000 description 3
- 201000001320 atherosclerosis Diseases 0.000 description 3
- 235000019658 bitter taste Nutrition 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 210000004027 cells Anatomy 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 230000000813 microbial Effects 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- -1 polyphenol compounds Chemical class 0.000 description 3
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 238000003672 processing method Methods 0.000 description 3
- XBDQKXXYIPTUBI-UHFFFAOYSA-N propionic acid Chemical compound CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 description 2
- 229940009289 Bifidobacterium lactis Drugs 0.000 description 2
- 235000003717 Boswellia sacra Nutrition 0.000 description 2
- 240000007551 Boswellia serrata Species 0.000 description 2
- 235000012035 Boswellia serrata Nutrition 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butanoic acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- 208000002925 Dental Caries Diseases 0.000 description 2
- 206010012601 Diabetes mellitus Diseases 0.000 description 2
- 208000001848 Dysentery Diseases 0.000 description 2
- 229940032049 Enterococcus faecalis Drugs 0.000 description 2
- 241000194032 Enterococcus faecalis Species 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 230000036826 Excretion Effects 0.000 description 2
- 210000003608 Feces Anatomy 0.000 description 2
- 239000004863 Frankincense Substances 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N Gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 210000000987 Immune System Anatomy 0.000 description 2
- 241000186660 Lactobacillus Species 0.000 description 2
- 229940039696 Lactobacillus Drugs 0.000 description 2
- 244000199885 Lactobacillus bulgaricus Species 0.000 description 2
- 241001468157 Lactobacillus johnsonii Species 0.000 description 2
- 241000186869 Lactobacillus salivarius Species 0.000 description 2
- GUBGYTABKSRVRQ-UUNJERMWSA-N Lactose Natural products O([C@@H]1[C@H](O)[C@H](O)[C@H](O)O[C@@H]1CO)[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1 GUBGYTABKSRVRQ-UUNJERMWSA-N 0.000 description 2
- 210000004080 Milk Anatomy 0.000 description 2
- 210000003470 Mitochondria Anatomy 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 210000003491 Skin Anatomy 0.000 description 2
- 241000194017 Streptococcus Species 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000002019 anti-mutation Effects 0.000 description 2
- 230000000111 anti-oxidant Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000003115 biocidal Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 230000000271 cardiovascular Effects 0.000 description 2
- 230000000112 colonic Effects 0.000 description 2
- 210000002249 digestive system Anatomy 0.000 description 2
- 201000009910 diseases by infectious agent Diseases 0.000 description 2
- 239000008157 edible vegetable oil Substances 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 229930003935 flavonoids Natural products 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 235000012041 food component Nutrition 0.000 description 2
- 235000009569 green tea Nutrition 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 230000003859 lipid peroxidation Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000006011 modification reaction Methods 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 210000000056 organs Anatomy 0.000 description 2
- 238000005502 peroxidation Methods 0.000 description 2
- 150000007965 phenolic acids Chemical class 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000002000 scavenging Effects 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 230000004580 weight loss Effects 0.000 description 2
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 description 1
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 1
- VSCWAEJMTAWNJL-UHFFFAOYSA-K Aluminium chloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 1
- 229940064005 Antibiotic throat preparations Drugs 0.000 description 1
- 229940083879 Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE Drugs 0.000 description 1
- 229940042052 Antibiotics for systemic use Drugs 0.000 description 1
- 229940042786 Antitubercular Antibiotics Drugs 0.000 description 1
- 206010060965 Arterial stenosis Diseases 0.000 description 1
- 210000001367 Arteries Anatomy 0.000 description 1
- 240000008371 Bacillus subtilis Species 0.000 description 1
- 229940075615 Bacillus subtilis Drugs 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241000606125 Bacteroides Species 0.000 description 1
- 229940004120 Bifidobacterium Infantis Drugs 0.000 description 1
- 241000186016 Bifidobacterium bifidum Species 0.000 description 1
- 229940002008 Bifidobacterium bifidum Drugs 0.000 description 1
- 241000186015 Bifidobacterium longum subsp. infantis Species 0.000 description 1
- NNUSCVFWUPARGJ-UHFFFAOYSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=NC(CC=2[C](C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N=2)CCC(O)=O)=C(CCC(O)=O)[C]1C NNUSCVFWUPARGJ-UHFFFAOYSA-N 0.000 description 1
- 210000000988 Bone and Bones Anatomy 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N Butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 210000001736 Capillaries Anatomy 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- PFTAWBLQPZVEMU-DZGCQCFKSA-N Catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- 229940100626 Catechin Drugs 0.000 description 1
- 229950001002 Cianidanol Drugs 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241001464948 Coprococcus Species 0.000 description 1
- 208000004981 Coronary Disease Diseases 0.000 description 1
- 206010063057 Cystitis noninfective Diseases 0.000 description 1
- 231100000277 DNA damage Toxicity 0.000 description 1
- SBJKKFFYIZUCET-JLAZNSOCSA-N Dehydro-L-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(=O)C1=O SBJKKFFYIZUCET-JLAZNSOCSA-N 0.000 description 1
- 206010012742 Diarrhoea infectious Diseases 0.000 description 1
- 235000019749 Dry matter Nutrition 0.000 description 1
- 235000004418 Durio kutejensis Nutrition 0.000 description 1
- 241000588921 Enterobacteriaceae Species 0.000 description 1
- LSHVYAFMTMFKBA-TZIWHRDSSA-N Epicatechin gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=CC=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-TZIWHRDSSA-N 0.000 description 1
- 229940109526 Ery Drugs 0.000 description 1
- 241000186394 Eubacterium Species 0.000 description 1
- OHZCFWMJMWFNFP-UHFFFAOYSA-L Ferrous tartrate Chemical compound [Fe+2].[O-]C(=O)C(O)C(O)C([O-])=O OHZCFWMJMWFNFP-UHFFFAOYSA-L 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000605909 Fusobacterium Species 0.000 description 1
- 229940074391 Gallic acid Drugs 0.000 description 1
- WMBWREPUVVBILR-NQIIRXRSSA-N Gallocatechin gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-NQIIRXRSSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229940093922 Gynecological Antibiotics Drugs 0.000 description 1
- 108010023302 HDL Cholesterol Proteins 0.000 description 1
- 206010018987 Haemorrhage Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010021972 Inflammatory bowel disease Diseases 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 208000007906 Intestinal Disease Diseases 0.000 description 1
- RBTARNINKXHZNM-UHFFFAOYSA-K Iron(III) chloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
- 241000229754 Iva xanthiifolia Species 0.000 description 1
- 108010028554 LDL Cholesterol Proteins 0.000 description 1
- 229940004208 Lactobacillus bulgaricus Drugs 0.000 description 1
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 description 1
- 240000006024 Lactobacillus plantarum Species 0.000 description 1
- GUWSLQUAAYEZAF-UHFFFAOYSA-L Lead(II) acetate Chemical compound O1C(C)=O[Pb]21O=C(C)O2 GUWSLQUAAYEZAF-UHFFFAOYSA-L 0.000 description 1
- 102000003820 Lipoxygenases Human genes 0.000 description 1
- 108090000128 Lipoxygenases Proteins 0.000 description 1
- 210000004185 Liver Anatomy 0.000 description 1
- 206010025482 Malaise Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 230000036740 Metabolism Effects 0.000 description 1
- 210000000214 Mouth Anatomy 0.000 description 1
- 208000003067 Myocardial Ischemia Diseases 0.000 description 1
- 229940116542 OTHER NUTRIENTS in ATC Drugs 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 206010033971 Paratyphoid fever Diseases 0.000 description 1
- 241000191992 Peptostreptococcus Species 0.000 description 1
- 210000002381 Plasma Anatomy 0.000 description 1
- 210000003240 Portal Vein Anatomy 0.000 description 1
- OTYBMLCTZGSZBG-UHFFFAOYSA-L Potassium sulfate Chemical compound [K+].[K+].[O-]S([O-])(=O)=O OTYBMLCTZGSZBG-UHFFFAOYSA-L 0.000 description 1
- 241000186429 Propionibacterium Species 0.000 description 1
- 241000192142 Proteobacteria Species 0.000 description 1
- 230000002292 Radical scavenging Effects 0.000 description 1
- 241000702670 Rotavirus Species 0.000 description 1
- 241000192031 Ruminococcus Species 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- 241000607768 Shigella Species 0.000 description 1
- 206010040550 Shigella infection Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 244000057717 Streptococcus lactis Species 0.000 description 1
- 235000014897 Streptococcus lactis Nutrition 0.000 description 1
- 241000282890 Sus Species 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- 229940035295 Ting Drugs 0.000 description 1
- 229940024982 Topical Antifungal Antibiotics Drugs 0.000 description 1
- 231100000765 Toxin Toxicity 0.000 description 1
- 210000001215 Vagina Anatomy 0.000 description 1
- 241001148134 Veillonella Species 0.000 description 1
- 235000005811 Viola adunca Nutrition 0.000 description 1
- 240000009038 Viola odorata Species 0.000 description 1
- 235000013487 Viola odorata Nutrition 0.000 description 1
- 235000002254 Viola papilionacea Nutrition 0.000 description 1
- 206010064899 Vulvovaginal mycotic infection Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229930013930 alkaloids Natural products 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 235000008758 anthocyanidins Nutrition 0.000 description 1
- 150000001453 anthocyanidins Chemical class 0.000 description 1
- 229930014669 anthocyanidins Natural products 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial Effects 0.000 description 1
- 230000003217 anti-cancerogenic Effects 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 244000052616 bacterial pathogens Species 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 235000020279 black tea Nutrition 0.000 description 1
- 230000000740 bleeding Effects 0.000 description 1
- 231100000319 bleeding Toxicity 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 230000000711 cancerogenic Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 229930002875 chlorophylls Natural products 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 201000008739 coronary artery disease Diseases 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000001877 deodorizing Effects 0.000 description 1
- 230000001066 destructive Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 235000021271 drinking Nutrition 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 1
- 230000029578 entry into host Effects 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 238000005562 fading Methods 0.000 description 1
- 230000004634 feeding behavior Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 229940057006 ferrous tartrate Drugs 0.000 description 1
- 150000002206 flavanols Chemical class 0.000 description 1
- 229930003947 flavanols Natural products 0.000 description 1
- 235000011987 flavanols Nutrition 0.000 description 1
- 150000002217 flavonols Chemical class 0.000 description 1
- 229930003933 flavonols Natural products 0.000 description 1
- 235000011957 flavonols Nutrition 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- 239000005428 food component Substances 0.000 description 1
- 238000005755 formation reaction Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 230000002496 gastric Effects 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 229910001385 heavy metal Chemical class 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 229940079866 intestinal antibiotics Drugs 0.000 description 1
- 210000002490 intestinal epithelial cell Anatomy 0.000 description 1
- 201000010538 lactose intolerance Diseases 0.000 description 1
- 229940046892 lead acetate Drugs 0.000 description 1
- 108010022197 lipoprotein cholesterol Proteins 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 150000004667 medium chain fatty acids Chemical class 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000035786 metabolism Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000002906 microbiologic Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-M nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 1
- 230000003000 nontoxic Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 229940005935 ophthalmologic Antibiotics Drugs 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000010461 other edible oil Substances 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001590 oxidative Effects 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N p-acetaminophenol Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052939 potassium sulfate Inorganic materials 0.000 description 1
- 235000011151 potassium sulphates Nutrition 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000001737 promoting Effects 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 230000001681 protective Effects 0.000 description 1
- 238000006479 redox reaction Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 231100000486 side effect Toxicity 0.000 description 1
- 230000031068 symbiosis, encompassing mutualism through parasitism Effects 0.000 description 1
- 201000010874 syndrome Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing Effects 0.000 description 1
- 231100000730 tolerability Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 108020003112 toxins Proteins 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
Abstract
The invention relates to the field of probiotic drops, more specifically, it relates to an oil-based probiotic drops and a preparation method thereof. The probiotic drops of the present invention, wherein the oil includes the following components by weight: 2.5-4.5g of olive oil, 4-8g of medium chain triglycerides; and the following substances are also added: 0.08-0.2g of probiotics . The invention has the following beneficial effects: the raw materials are medium-chain triglycerides with high stability and olive oil containing a large amount of monounsaturated fatty acids, and the safety is high. Medium-chain triglycerides can be broken down into human functions in a short time without forming fat accumulation in the body. Olive oil can reduce the blood lipids and cholesterol in the human blood, prevent the occurrence of cardiovascular and cerebrovascular diseases, and provide the human body with a variety of vitamins. The preparation method of the oil agent provided by the invention is simple and easy to operate. The stability of probiotics is higher than other products in the prior art. n triglycerides; and the following substances are also added: 0.08-0.2g of probiotics . The invention has the following beneficial effects: the raw materials are medium-chain triglycerides with high stability and olive oil containing a large amount of monounsaturated fatty acids, and the safety is high. Medium-chain triglycerides can be broken down into human functions in a short time without forming fat accumulation in the body. Olive oil can reduce the blood lipids and cholesterol in the human blood, prevent the occurrence of cardiovascular and cerebrovascular diseases, and provide the human body with a variety of vitamins. The preparation method of the oil agent provided by the invention is simple and easy to operate. The stability of probiotics is higher than other products in the prior art.
Description
TITLE
Probiotic drops and preparation method
TECHNICAL FIELD
The invention relates to the field of probiotic drops, more specifically, it relates to an
oil-based probiotic drops and its preparation method.
BACKGROUND OF THE INVENTION
Oil plays an indispensable role in human life. It is one of the six nutrients required by the
human body and provides energy for human ties. Too much or too little intake of
fats will affect the health of the human body and cause diseases. However, there are
many types of edible oil on the market, and the ition ratio of different oils is
different. The pment of an oil agent that can supplement the nts required by
the human body will have social significance and health care value.
More than 99% of oil is fat, and fat contains different types of fatty acids. According to the
structure of fatty acids, it can be divided into saturated fatty acids and unsaturated fatty
acids. Most saturated fatty acids are derived from animal fats and a few vegetable fats,
such as coconut oil and palm oil. Studies have shown that excessive intake of ted
fatty acids can lead to increased blood cholesterol, lglycerol and nsity
lipoprotein cholesterol in the body, which may cause arterial stenosis, atherosclerosis,
and increase the probability of coronary heart disease, is not conducive to the health of
cardiovascular and cerebrovascular. Unsaturated fatty acids can be divided into
monounsaturated fatty acids and polyunsaturated fatty acids. Contrary to saturated fatty
acids, unsaturated fatty acids are ed in the synthesis of essential nutrients for the
human body, such as DHA and EPA, which can effectively reduce the content of human
cholesterol and triglycerides, increase the t of high-density lipoprotein cholesterol,
and effectively control the level of human blood lipids. At the same time, reduce blood
viscosity, it can also effectively enhance the body's immunity, protect the elasticity of
blood vessels and prevent cardiovascular diseases. However, due to the presence of
multiple unsaturated bonds in polyunsaturated fatty acids, their stability is worse than that
of saturated fatty acids, and they are prone to peroxidation by lipids.
Olive oil is a kind of vegetable oil, rich in monounsaturated fatty acids. Saturated fatty
acids in olive oil: monounsaturated fatty acids: polyunsaturated fatty acids are about
1.3:6.9:1, and the content of monounsaturated fatty acids in some olive oils can even
reach more than 80%. It can reduce blood cholesterol, cerides and low-density
lipoprotein cholesterol content, control blood viscosity, and protect cardiovascular and
cerebrovascular health accidents. Due to its chemical structure, it also has high stability
and is not easy to be peroxidized by . Australian oil researchers found that even
under heating conditions, the properties of olive oil are very stable, and the harmful polar
compounds produced are half or less of other edible oils. In addition, olive oil is also rich
in vitamins A, B, D, E, K and antioxidants, which are anti-aging for the human body,
protect the skin, beauty, prevent bone fragility, e the function of the digestive
system, and remove free radicals in the body Has a positive effect.
Medium-chain triglycerides (MCT), as the name implies, are a kind of medium-chain fatty
acids, which contain only a small amount of unsaturated fatty acids, so their stability is
extremely high regardless of high temperature or low ature. In addition,
medium-chain triglycerides are easy to be digested and absorbed by the human body
due to their small relative molecular weight and short carbon chain, and are easily
compatible with other organic solvents, oils or fat-soluble vitamins. When MCT enters the
human body, it can be rapidly hydrolyzed in the ine, absorbed by the intestinal
epithelial cells, and then enter the blood circulation through the c portal vein. It is
worth noting that MCT can enter the mitochondria to provide energy for oxidation and
decomposition without the transport of the L-carnitine shuttle system, and because the
shorter carbon chain cannot be used as a structural material for fat cells. In other words,
MCT can supply energy to the body at any time t being stored as fat. Due to its
special properties, medium-chain triglycerides have been clinically applied for more than
60 years. It can be used to help patients with fat indigestion prevent the occurrence of
malnutrition and help obese patients control weight gain and weight loss. Studies have
shown that 44% of diabetes, 23% of ischemic heart disease and some cancers are
inextricably linked to obesity, so preventing obesity also prevents many other es
from occurring to a n . In on to this accident, MCT can also improve the
lism of human sugar, fat and cholesterol, and help the body relieve fatigue by
providing a lot of energy. Most importantly, clinical studies and multiple animal
experiments have proven that MCT has good tolerability and extremely high safety, and
can be eaten with confidence.
Generally speaking, tics (Probiotics) refer to edible microorganisms that have a
positive effect on the host (such as animals or humans) after consumption. They can
adjust the intestinal flora, improve the human micro-ecological balance, and inhibit
harmful pathogenic microorganisms in the human body. The active ingredients in the
probiotic micro-ecological capsules are live tic bacteria. At present, common
probiotic bacteria include lactic acid bacteria, bifidobacteria, Lactobacillus bulgaricus,
ococcus thermophilus, etc. Commercial probiotic microecological preparations are
mostly sed by nding bacterial powder of a single bacterial species and
auxiliary materials. After multiple processing of bacterial powder, the ty of bacterial
species decreases, which is not enough to achieve the expected health care effect.
Probiotics are living microorganisms. When used in humans or animals, they promote the
health of the host by improving the inal microbial balance (Fuller, R. Probiotics for
Humans and Animals, 1989, J. Appl. Microbiol. 66: 365-378 ). The ture records that
probiotics include L. rhamnosus LGG, L. johnsonii (L. johnsonii) LAI, L. casei (L. casei)
Shirota and bacterium lactis (Bifidobacterium lactis) BbI2. In on, many other
probiotics are described in the literature in the field (see, for example, M.E. Sanders &
J.H. in't Veld 1999. Antonie van Leeuwenhoek 76:293-315, Kluwer Academic Publishers).
The role of probiotics to promote health includes the balance and maintenance of the
intestinal flora, the stimulation of the immune system and the anti-carcinogenic activity.
The beneficial effects of probiotics in the human intestine are based on several factors
caused by living ial cells, their cell structure and metabolites. Probiotics are usually
administered in nutritional products or as capsules. If a n kind of bacteria basically
meets the following requirements, it can be called a probiotic, that is: it can in
vitality under the harsh conditions generally in the digestive tract (low pH of the stomach,
y of the digestive system, etc.); It can usually attached on to the intestinal wall; It is
lized in the intestine; It is technically applicable (tolerable processing); It
demonstrated clinically tested and reported health effects; and it is safe to eat (Lee, YK
and Salminen, S. 1995 The coming era of probiotics,Trend Food Sci Technol,
245).
The intestine is a complex micro-ecosystem, in which there are billions of different types
of microorganisms in the inner mucosa. The probiotics in the gastrointestinal tract help
maintain the health of the host gastrointestinal tract. The host gastrointestinal tract
provides the place and support needed by probiotic bacteria, and a variety of foods. In
return, they provide the host with a variety of potential treatments, changing the
destructive effect of gastrointestinal bacteria through antibiotics; g ion and
inhibiting bacteria that cause diseases ; Treatment and tion of diarrhea, including
infectious diarrhea, especially rotavirus that causes diarrhea in children; ent of
so-called "harmful" biological overgrowth in the gastrointestinal tract; alleviation of
symptoms of polar bowel syndrome, inflammatory bowel disease; prevention and / or
reduce the recurrence of vaginal yeast infections, y tract infections, and bladder
inflammation; improve the absorption and digestion of lactose in people with lactose
intolerance; and enhance the compilation response. Because tics have many
beneficial effects, probiotics need to be supplemented.
The human digestive tract contains a large number of bacteria that live in symbiosis with
the host. The t of microorganisms varies greatly between different parts of the
digestive tract. About 95% of all inal bacteria occur in the colon, which is the most
important part of the intestine. It is estimated that more than 400 bacterial species are
thriving in the colon. In addition to these, the ine also contains microorganisms
called temporary microorganisms (GRGibson and MBRoberfroid (editors) "Colonic
Microbiota: Nutrition and Health" (Colonic Microbiota; Nutrition and Health.) Kluwer
Academic her, Dordrecht, 1999 ). The dominant probiotics species are as follows:
Bacteroides, Bifidobacterium, Coprococcus, Peptostreptococcus, Eubacterium, and
Ruminococcus. Lactobacillus, Streptococcus, Fusobacterium, Veillonella,
Propionibacterium, and Enterobacteriaceae (have slightly fewer s). Some of these
species are useful rganisms, while others may even be l. The average
microbial content in feces is 1012cfu/g (per dry matter). Bacteria degrade and ferment
those food components that are not absorbed in the small intestine in the colon, and the
body can use the fermentation end products absorbed by the small intestine. In addition
to nutrition, the microbial balance in the colon is of great significance to human health
(Tannock, G.W. 1998. Research on the inal microbiota: the prerequisites for the
development of probiotics Int. Dairy J. 8: 527-533). Changes in the composition of the
intestinal flora or a sudden decrease in its number (due to severe diarrhea, antibiotic
treatment, etc.) will increase the infectivity of potential pathogenic species, which may
cause serious consequences (onset of allergies, intestinal diseases, cancer). Probiotics
that can be supplemented usually include: acidophilus, L. bulgaricus, L. plantarum, L.
casei, Bifidobacterium bif idum, L. yeast , Lactobacillus rhamnosus (L.rhamnosus),
Lactobacillus salivarius (L.salivarius), Bifidobacterium infantis antis), B.animal is
subsp, lactis, long double Fidobacterium (B.1ongum), ococcus thermophilis, and
Enterococcus faecalis (Enterococcus faecalis) are all found in the human gastrointestinal
tract and/or vagina. Lactic acid bacteria are gram-positive lactic acid bacteria, which
absorb lactose and other monosaccharides in the intestinal tract and produce lactic acid,
which helps to reduce the pH of the organs and makes the organ environment
unfavorable for the production of harmful bacteria.
Tea polyphenols have a wide range of inhibitory effects on ia, and have obvious
tory effects on pathogenic bacteria such as typhoid bacillus, paratyphoid bacillus,
lococcus aureus, dysentery, a, etc., with a concentration of 0.08% to 0.1%,
against fungi and yeast, Lactic acid bacteria and acetic acid bacteria have no tory
effect. It can effectively t the oral streptococcus s that causes dental caries in
the oral cavity, and the effect of preventing dental caries is better than that of fluoride. In
addition, tea polyphenols have biological functions such as xidation, anti-mutation,
anti-cancer, anti-aging, scavenging free ls, lowering blood pressure and cholesterol.
Tea enols have strong polarity and a n degree of hydrophilicity. Natural
antioxidants. When tea polyphenols meet ferric chloride, green-black or blue-black
precipitates are formed, and some tea polyphenols meet gelatin to produce off-white
precipitates. The effect of tea polyphenols and heavy metal salt solutions such as 1%
aluminum trichloride or basic lead acetate in water produces a gray-yellow precipitate. It
can also be oxidized by potassium ganate, potassium sulfate and other oxidants,
and form a blue-violet complex with ferrous tartrate.
The main medicinal effects of tea polyphenols are: (1) Lower blood lipids and inhibit
atherosclerosis. Many studies have shown that drinking tea can reduce the blood
cholesterol content and has obvious therosclerosis function. This is because tea
polyphenol compounds play an important role in the body’s fat metabolism, inhibiting the
increase in terol levels in plasma and liver, and promoting the excretion of lipid
nds from feces. Therefore, it can not only prevent arteries Atherosclerosis, but
also has the effect of weight loss. (2) Strengthen capillaries and lower blood sugar. Tea
polyphenols can not only prevent the increase in microvascular permeability caused by
excessive fat, but also work together with tea alkaloids to relax the blood vessel wall and
increase the ive diameter, which is beneficial to the relaxation of human blood
vessels and enhances the toughness of microvascular walls. Play a role in preventing
rupture of blood vessels. Experiments show that catechins can also effectively lower
blood sugar and reduce the risk of diabetes. (3) Radiation resistance. Regarding tea
anti-radiation, it was first reported by Japan. They found that among the survivors of the
nuclear bomb, those who drank tea frequently had less radiation sickness. A series of
animal experiments show that tea polyphenols have obvious anti-radiation s. It is
generally believed that the anti-radiation effect of tea polyphenols is related to the
participation of tea polyphenols in redox reactions in the body, protection of blood, repair
of physiological functions, and inhibition of al bleeding. In addition, tea enols
can reduce DNA damage caused by radiation. (4) Anti-aging. Lipid peroxidation in the
human body is one of the isms of human aging, and free radicals are the main
factor of peroxidation in the sm. Tea polyphenols have a strong effect of
scavenging free radicals, which can play an anti-oxidation and anti-aging effect. Animal
experiments show that tea polyphenols can inhibit lipoxygenase activity and lipid
peroxidation in skin mitochondria. (5) Anti-cancer and anti-mutation. Free ls may
play a certain role in the process of carcinogenesis, so the free radical scavenging effect
of tea polyphenols can play an anti-cancer effect.
STATEMENT OF ION
The purpose of the present invention is to provide a health-care probiotic containing a
large amount of medium-chain triglycerides and olive oil, which helps the human body
maintain health while ng fat accumulation, helps the human body reduce blood fat
and cholesterol levels, and supplements multiple vitamins. The preparation method
provided by the invention is simple, the t tastes good, the nutritional components
are easy to maintain, the stability is high, and the product shelf life is long.
The purpose of the present invention is achieved through the ing technical
solutions:
A health oil for strengthening human health, enhancing immunity and regulating the
intestines and stomach. The oil comprises the following components by weight: 2.5-4.5g
of olive oil, 4-8g of medium chain cerides, and the following substances are also
added:
Probiotics 0.08-0.2g;
Preferably, 3g olive oil, 6.282g medium-chain cerides, and add the following
substances:
0.12g of probiotics;
Among them, the tics consists various bacteria, and the following ratios are
preferred:
M-16V Bifidobacterium breve 100B/g
Among them, Equiv. to 5b cfu/bottle is equivalent to 50 billion CFU per bottle
HN001 Lactobacillus rhamnosus 450B
Among them, Equiv. to 15b cfu/bottle is equivalent to 150 billion CFU per bottle
HN019 Bifidobacterium lactis 300B cfu/g
Among them, Equiv. to 10b cfu/bottle is equivalent to 100 billion CFU per bottle.
The combination ratio of the above-mentioned probiotics has been tested for many times.
The combined probiotics can very well regulate the human intestines and stomach and
increase immunity. The taste is also very good, and it is also very uniform after being
mixed with olive oil.
The mentioned selected probiotic ation, among them, Bifidobacterium
breve can enhance the body's own ability to produce interferon, then the body's
own resistance, se its own resistance, repair cells damaged by bacterial invasion
or medical treatment, and enhance the vitality of life and quality.
Bifidobacterium breve has an inhibitory effect on spoilage bacteria and pathogenic
bacteria, pathogenic Escherichia coli, Staphylococcus , Shigella ery,
Salmonella typhi, and Proteobacteria. It will gradually decrease with age, and bad diet or
living habits will greatly reduce the amount of Bifidobacterium breve. Lactobacillus
sus is a non-toxic and non-side-effect probiotic. Its functional properties mainly
e tion of intestinal flora, prevention and treatment of diarrhea, excretion of
toxins and enhancement of body immunity. It has high application value and conforms to
the basic needs of modern human health care.
Bifidobacterium and lactic acid bacteria and other beneficial bacteria can t the
growth of harmful bacteria in the human body, resist the infection of pathogenic bacteria,
synthesize vitamins needed by the human body, promote the absorption of minerals by
the human body, and produce organic acid stimulation such as acetic acid, propionic acid,
butyric acid and lactic acid Intestinal peristalsis, promote tion, prevent constipation,
inhibit intestinal corruption, purify the intestinal environment, decompose carcinogens,
stimulate the human immune system, and thus play an important role in improving
disease resistance.
The oil also includes 0.0024-0.006 g of tea polyphenols.
The tea polyphenols preferably used in the present invention are powdered solids. The
properties of the preferred tea polyphenols are as follows: light yellow to brown
tea-flavored aqueous solution, powdered solid or l, with astringent taste, easily
soluble in water and l, Ethyl acetate, slightly soluble in fat. It has good heat
resistance and 5 acid resistance, and it is very stable in the range of pH=2~7. Slightly
hygroscopic, pH of aqueous solution=3~4. It is easy to oxidize and brown under alkaline
conditions. Catechins account for about 60% to 80% of the total amount of tea
polyphenols. Among the polyphenols extracted from green tea and its by-products, the
content of tea polyphenols is greater than 95%, of which catechins 70%~80%; flavonoids
4%~10%; gallic acid 0.3%~0.5%; Amino acid .5%; total sugar content 0.5%~
1.0%. Chlorophyll is mainly pheophytin, with a content of 0.01% to 0.05%.
Tea polyphenols have a strong antioxidant effect, especially the ester-type catechin
EGCG, whose reduction can even reach 100 times that of L-isocorbic acid. Among the
four main catechin compounds, the antioxidant capacity is GC>ECG>EC>BHA,
and the antioxidant capacity increases with the increase of temperature. In addition to
antioxidant effects, tea polyphenols also have antibacterial effects, such as inhibitory
effects on lococcus, Escherichia coli and Bacillus subtilis. Tea enols can
absorb peculiar smell in food, so it has a certain deodorizing effect. It has a protective
effect on the pigment in food. It can not only play the role of natural pigment, but also
prevent food from fading. Tea polyphenols also have the effect of inhibiting the formation
and accumulation of nitrite.
One of the highlight of this ions is that, the addition of tea polyphenols protects the
oil base of olive oil and r protects other nutrients added to the oil base.
lly, a simple mixing method can be used for mixing. For example, the following
preparation method of health oil for strengthening human health, enhancing ty
and ting the intestines and stomach es the following steps:
1) Weigh all the raw materials according to the above-mentioned weight ratio for use.
2) Mix olive oil and medium-chain triglycerides (preferably, tea polyphenols can also be
added at the same time), mix them evenly by stirring, and place them at 30℃-35℃ for
later use.
3) The mixture ed in step (2) is filtered through a precision filter and then canned
into a bottle.
4) Put the finished product obtained in step (3) into an ultraviolet ization device for
sterilization.
Preferably, the inventors creatively improved the processing method to further improve
the stability of the final product:
Before mixing olive oil and MCT, premix MCT and tea polyphenols. This step is very
important. Otherwise, problems of poor anti-oxidation effect and uneven mixing will occur.
The ic operation methods are as follows:
) MCT and tea polyphenols are mixed under vacuum at room temperature (for example,
from 20°C to 30°C); preferably, the riate vacuum pressure is less than 7 Torr;
preferably, the tea polyphenols are milled to an average particle size of about 10 μm to
about 1000μm powder belongs to the preferred addition range of the present ion;
6) In order to maximize the stability of the final product, it is preferable to reduce the
water activity of the oil agent after mixing to Aw less than 0.1 or lower;
7) Then it is heated to 40-50℃ and kept for 60-120 minutes after one time;
8) After cooling down to room temperature, set aside, and mix with olive oil and
probiotics.
The pre-mixing method is an important invention of the present invention. This is
because after the powder and oil are fully mixed at room temperature, there is a
linking time. After testing, just mixing at room temperature does not guarantee a
long time. After precipitation, after many tests, after heating up and maintaining a period
of time, the final product will maintain a uniform state for a long time, and it has a very
good effect to maintain the consistency of the final product.
In the above method, ably, the first) above is treated at 20-100 rpm for 5-50
minutes. After many tests, the effect of simple stirring and mixing is far inferior to regular
stirring.
In summary, the present invention has the following beneficial effects:
(1) The raw als are -chain triglycerides with high stability and olive oil
containing a large amount of monounsaturated fatty acids, which has high safety.
(2) Medium-chain triglycerides can be decomposed into human body functions in a short
time without forming fat accumulation in the body.
(3) Olive oil can reduce blood lipids and cholesterol in human blood, prevent
cardiovascular and cerebrovascular diseases, and provide a variety of vitamins for the
human body.
(4) The ation method of the oil agent provided by the present ion is simple
and easy to operate.
(5) The activity and ity of probiotics are protected to the st . Thanks to
the joint action of olive oil and tea polyphenols, the antioxidant properties of tea
polyphenols make olive oil very good in antioxidant properties. The joint action protects
the stability of probiotics.
Tea polyphenols being the antioxidant, which further protects olive oil from being oxidized.
High quality olive oil can further protect nutrients from damage and maximize the shelf
life of the product; tea polyphenols refer to the compound made up from
catechins(flavanols), flavonoids and flavonols, anthocyanidins, phenolic acid and depsilic
acid polyphenol compounds, regarding their structures, except for phenolic acid and
depsilic acid, they both have 2- C6-C3-C6 basic carbon ork with phenylchroman
(flavan) as the main body, of which catechin compounds are the main components of tea
polyphenols, accounting for about 50% of the total tea polyphenols~ 70%, accounting for
12% to 24% of the dry weight of tea, is a kind of compound with a relatively complex
structure, including catechins, atechins, gallocatechin gallate, catechin gallate, etc.
The content of tea polyphenols in tea is roughly that green tea is more than black tea,
and summer and autumn tea are more than spring tea.
DETAILED DESCRIPTION OF THE INVENTION
The embodiments of the present invention are intended to be illustrative, and not to limit
the scope of the present invention. Any slight difference in nutrient composition due to
the difference in milk source should not be used as a reason for the istency
between the ment of the present invention and the specification, so the present
invention aims to protect the purpose of adding nutrients, rather than to make the ratio
particularly strict. The ground is limited to a specific value.
In the following, the present invention will be further bed in conjunction with the
embodiments:
Example 1
A health oil for strengthening human health, enhancing immunity and regulating the
intestines and stomach. The oil comprises the following ents by : 3g olive
oil, 6.282g medium chain triglycerides, and the following substances are added: 0.12g
tics ;
The preparation method of the health oil for strengthening human health,
enhancing immunity and regulating intestines and stomach includes the following steps:
(1) Weigh all the raw materials according to the above-mentioned parts by weight
ratio.
(2) Mix olive oil and medium-chain triglycerides , and place them at 32.5 ℃
for later use.
(3) The mixture obtained in step (2) is filtered through a precision filter and then
canned and bottled.
(4) Put the finished product obtained in step (3) into an ultraviolet sterilizer for
sterilization.
Before mixing olive oil and MCT, premix MCT and tea polyphenols. This step is
very important. Otherwise, ms of poor anti-oxidation effect and uneven mixing will
occur. The specific operation methods are as follows:
1) MCT and 0.004 tea polyphenols are mixed at room temperature (25℃) under
vacuum;
2) Then it is heated to 45℃ for 90 minutes after one time;
3) After cooling down to room temperature, set aside, and mix with olive oil and
tics.
Example 2
A health oil for strengthening human health, enhancing immunity and regulating the
intestines and stomach. The oil comprises the following components by weight: 2.5 g of
olive oil, 4 g of medium chain triglycerides, and the ing substances are added:
probiotics 0.08 g;
The preparation method of the health oil for strengthening human health, enhancing
immunity and regulating intestines and stomach includes the following steps:
(1) Weigh all the raw materials according to the above-mentioned parts by weight ratio.
(2) Mix olive oil and medium-chain triglycerides evenly, and place them at 30°C for later
(3) The mixture obtained in step (2) is filtered h a precision filter and then canned
and bottled.
(4) Put the finished product obtained in step (3) into an ultraviolet sterilizer for
sterilization.
Preferably, the inventors creatively improved the processing method to further improve
the stability of the final product:
Before mixing olive oil and MCT, premix MCT and tea polyphenols. This step is very
ant. Otherwise, problems of poor anti-oxidation effect and uneven mixing will occur.
The specific operation methods are as s:
1) MCT and tea polyphenols are mixed under vacuum at room temperature (20°C) and
50 rpm for 30 minutes; preferably, the appropriate vacuum pressure is lower than 7 Torr;
preferably, the tea polyphenols are milled to an average particle size of about 500μm The
powder belongs to the red addition range of the present invention;
2) In order to maximize the stability of the final product, it is preferable to reduce the
water activity of the oil agent after mixing to Aw less than 0.1 or lower;
3) Then it is raised to 40℃ for 60 minutes after one time;
4) After cooling down to room temperature, set aside, and mix with olive oil and
probiotics.
Example 3
A health oil for strengthening human health, enhancing immunity and regulating the
ines and stomach, the oil comprising the following components by : 4.5 g of
olive oil, 8 g of medium chain triglycerides, and the following substances: probiotics 0.2 g;
The preparation method of the health oil for strengthening human health, enhancing
immunity and regulating intestines and h includes the following steps:
(1) Weigh all the raw als according to the above-mentioned parts by weight ratio.
(2) Mix olive oil and medium-chain triglycerides evenly, and place them at 33°C for later
(3) The e obtained in step (2) is filtered h a precision filter and then canned
and bottled.
(4) Put the finished product obtained in step (3) into an ultraviolet sterilizer for
sterilization.
Before mixing olive oil and MCT, premix MCT and tea polyphenols. This step is very
important. Otherwise, ms of poor anti-oxidation effect and uneven mixing will occur.
The specific operation methods are as follows:
1) MCT and 0.006 g of tea polyphenols are mixed at room temperature (23°C) under
vacuum;
2) Then it is heated to 43℃ for 70 minutes after one time;
3) After cooling down to room temperature, set aside, and mix with olive oil and
tics.
Example 4
A health oil for strengthening human health, enhancing immunity and regulating the
intestines and stomach. The oil comprises the ing components by weight: 4.5 g of
olive oil, 4 g of medium chain cerides, and the following substances: probiotics 0.2 g;
The preparation method of the health oil for strengthening human health, enhancing
immunity and regulating intestines and h includes the following steps:
(1) Weigh all the raw materials according to the mentioned parts by weight ratio.
(2) Mix olive oil and medium-chain triglycerides evenly and place them at 34°C for later
(3) The mixture obtained in step (2) is filtered through a precision filter and then canned
and bottled.
(4) Put the finished product obtained in step (3) into an ultraviolet sterilizer for
sterilization.
Before mixing olive oil and MCT, premix MCT and tea polyphenols. This step is very
important. Otherwise, problems of poor anti-oxidation effect and uneven mixing will occur.
The specific operation methods are as follows:
1) MCT and 0.0024g tea polyphenols are mixed at room temperature (28 ℃ ) under
vacuum;
2) Then, it is heated to 48℃ for 110 minutes after one time;
3) After cooling down to room temperature, set aside, and mix with olive oil and
probiotics.
Example 5
A health oil for strengthening human health, enhancing immunity and regulating the
intestines and stomach. The oil includes the following components by : 3.5 g of
olive oil, 5 g of medium chain triglycerides, and the following substances are also added:
probiotics 12 g;
The preparation method of the health oil for thening human health, enhancing
ty and regulating ines and stomach includes the following steps:
(1) Weigh all the raw materials according to the above-mentioned parts by weight ratio.
(2) Mix olive oil and medium-chain cerides evenly, and place them at 35 ℃ for later
(3) The e obtained in step (2) is ed through a precision filter and then canned
and bottled.
(4) Put the finished product obtained in step (3) into an ultraviolet sterilizer for
sterilization.
Preferably, the inventors creatively improved the processing method to further improve
the stability of the final product:
Before mixing olive oil and MCT, premix MCT and tea polyphenols. This step is very
important. Otherwise, problems of poor anti-oxidation effect and uneven mixing will occur.
The specific ion methods are as follows:
1) MCT and 0.003 g of tea polyphenols are mixed under vacuum at room temperature
(30°C) at 100 rpm for 50 minutes; preferably, the tea polyphenols are milled into powder
with an average particle size of about 1000 μm, which belongs to the preferred addition
range of the present invention;
2) In order to maximize the stability of the final product, it is preferable to reduce the
water activity of the oil agent after mixing to Aw less than 0.1 or lower;
3) Then it is raised to 50℃ for 120 minutes after one time;
4) After g down to room temperature, set aside, and mix with olive oil and
probiotics.
Product Sensory Evaluation:
With reference to the sensory evaluation standard of edible oil, sensory evaluation was
performed on the oil agents of Examples 1-3 and Comparative Examples of the present
invention. Fifty consumers are randomly selected for sensory evaluation. The evaluation
adopts a blind evaluation method. The evaluation criteria are shown in Table 1:
Table 1 Sensory evaluation standards of health oil
Test item Score Feature
ption
1 Dislike very much
2 dislike
The smell of oil 3 general
4 like
Like very much
1 Dislike very much
2 dislike
Overall preference 3 general
4 like
Like very much
The evaluation scores are averaged, and the results are shown in Table 2. Table 2
shows the y evaluation results of the oils prepared in Examples 1-3 and
Comparative Examples:
Table 2: The present invention is the sensory evaluation results of the oils prepared in
Examples 1-3 and Comparative Examples of the present invention
Smell of oil overall preference
Example1 4.29 4.27
Example2 4.38 4.37
Example3 4.42 4.49
Comparative example 4.02 4.01
It can be seen from Table 2 that the sensory evaluation odor of the oil preparations
prepared in Examples 1-3 is 4.36 points, and the overall preference is 4.38 points.
About the stability test:
We have done long-term stability test (shelf life and room temperature retention sample)
and accelerated test (6 months), which fully meets the standard requirements. The
s were stored under different conditions, the temperature varies from 4 degrees to
50 degrees, and different light conditions; evaluate the products at different time intervals,
typically 2, 4, 8 and 12 weeks, do the microbiological challenge test; ine the
sample If the sample remains ged for 8 weeks at high temperature, it should be
stable for 1 year at room ature.
Sensory evaluation:
Table 1 is the scoring standard for the uniformity of probiotics and the taste of the final
product
Scoring criteria
score Grade
Uniformity odor
Sinking time ≤10 seconds; number of white tics have a
Very spots ≤10; no white spots on the cup wall; no unique fragrance,
good clumps the smell is l
t bitterness
11 seconds ≤ sinking time ≤ 20 seconds; a small The special
8-9 Good amount of small white spots, small particles; the frankincense of
number of small white spots and flakes on the probiotics is not
cup wall ≤ 10; 1 ≤ clumps ≤ 5; small clumps strong, slightly
bitter
21 seconds ≤ sinking time ≤ 30 seconds; a small The frankincense
amount of small white spots, small particles characteristic of
around the small white spots; a small amount of probiotics is not
6-7 general small white spots and flakes on the wall of the strong, with a slight
cup; 1 ≤ clump ≤ 5; large clumps vegetable oil taste
and a slight bitter
taste
31 seconds ≤ sinking time ≤ 40 seconds; a large There are other
number of small white spots and flakes, no peculiar smells,
3-5 s ence between the middle and the relatively strong
surrounding area; 6 ≤ clumps ≤ 10; clumps are bitter flavour
larger
41 seconds ≤ sinking time; a large number of The milk smell is
small white spots and flakes, there is no obvious not strong and
very difference between the middle and the
<3 there are other
bad nding; 11 ≤ clumps; there are a large
number of small white spots and flakes on the peculiar smells,
wall of the cup that do not fall strong bitterness
According to the above criteria, the scores of Examples 1-3 of the t invention are
as follows: Table 2 Table 2 Scores of the embodiment of the t invention (25 people
in the evaluation group, average scores, individual detail scores are not attached due to
space limitations, only the average score with two decimal places after the decimal point
is attached)
Score
Uniformity smell
Example 1 9.28 9.56
Example 2 9.19 9.59
Example 3 9.31 9.48
The above are only preferred embodiments of the present ion and are not intended
to limit the present invention in other forms. Anyone familiar with the profession may use
the technical t disclosed above to change or modify the equivalent of equivalent
changes. However, any simple modifications, lent changes and modifications
made to the above embodiments according to the technical essence of the present
invention without departing from the content of the technical on of the present
invention still belong to the protection scope of the technical solution of the present
invention.
Claims (5)
1. A probiotic drop, characterized in that: the oil includes the following components by weight: 2.5-4.5 g of olive oil and 4-8 g of medium chain triglycerides; The following substances are also added: 0.08-0.2g of probiotics.
2. The probiotic drops according to claim 1, characterized in that: preferably, olive oil 3g, medium chain triglycerides 6.282g, and probiotics 0.12g.
3. The probiotic drops according to claim 1, wherein the oil further ses 0.0024-0.006g of tea polyphenols.
4. The preparation method of probiotic drops according to claim 1 or 2, characterized in that: the preparation method comprises the following steps: 1) Weigh all the raw materials according to the above-mentioned weight ratio for use; 2) Mix olive oil and medium-chain cerides (preferably, tea polyphenols can also be added at the same time), mix them evenly by stirring, and place them at 30℃-35℃ for later use; 3) The mixture obtained in step (2) is filtered through a precision filter and then canned into a bottle; 4) Put the finished product obtained in step (3) into an ultraviolet sterilization device for sterilization.
5. The preparation method of probiotic drops according to claim 3, characterized in that: Before mixing olive oil and MCT, premix MCT and tea polyphenols, the specific ion method is as follows: 1) MCT and tea polyphenols are mixed under vacuum at room ature (for example, ranging from 20°C to 30°C); preferably, the appropriate vacuum re is less than 7 Torr; preferably, the tea enols are milled to an e particle size of about The powder of 10 μm to about 1000 μm belongs to the preferred addition range of the present invention; 2) In order to ze the stability of the final product, it is preferable to reduce the water activity of the oil agent after mixing to Aw less than 0.1 or lower; 3) Then it is raised to 40-50℃ and kept for 60-
Publications (1)
Publication Number | Publication Date |
---|---|
NZ773159A true NZ773159A (en) | 2021-02-26 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20080102061A1 (en) | Use hydrolyzed medium containing microorganisms medicinally | |
CN112716982B (en) | Lactic acid bacteria-containing composition and use thereof | |
CN112971145A (en) | Probiotic drop and preparation method thereof | |
KR20160105982A (en) | Agent for regulating composition ratio of intestinal bacterial flora | |
JP2015127340A (en) | Agent for regulating composition ratio of intestinal bacterial flora | |
JP2011519362A (en) | Effects of human and animal probiotics under environmental or biological changes | |
CN113925923B (en) | Anti-acne and whitening compound probiotic composition and preparation method thereof | |
CN107568736A (en) | Dealcoholic sobering-up medical science formula food | |
CN113413406A (en) | A metazoan compound, its preparation method and application in resisting helicobacter pylori and gastrointestinal diseases | |
CN109069555A (en) | Towards neonatal for improving the composition of brain function | |
CN108968037A (en) | Senile dementia full nutrition formula food | |
CN111034891A (en) | Solid beverage containing probiotic composition and preparation method thereof | |
JP2011116666A (en) | Anti-stress agent containing lactic bacterium-fermented royal jelly and method for producing the same | |
KR100872134B1 (en) | The livestock feed additive where the sterilization and anti germ effect increased and method of manufacturing thereof | |
CN108936628A (en) | A kind of specific full nutritional formulas and preparation method thereof that patients with cerebral apoplexy is edible | |
RU2671221C2 (en) | Compositions comprising mixture of bacteria comprising pedoiococcus and lactobacillus and methods for decreasing effects of alcohol | |
CN106954673A (en) | A kind of dairy products comprising probiotics and preparation method thereof | |
KR102615147B1 (en) | A cosmetic composition of fermented colostrum product for anti-acne | |
Onyenweaku et al. | Research Article Health Benefits of Probiotics | |
JP2016521287A6 (en) | Composition comprising a mixture of bacteria comprising Pediococcus and Lactobacillus, and method for reducing the effects of alcohol | |
CN108936607A (en) | Chronic Obstructive Pulmonary Disease full nutrition formula food | |
AU2021101165A4 (en) | Mushroom oil drops and its preparation method | |
JP2006055145A (en) | Pet food and method for offering the same | |
NZ773159A (en) | Probiotic drops and preparation method | |
Agbakoba | Essentials of nutraceuticals and probiotics |